Cardiotoxicity in Patients With Lung Cancer Receiving Thoracic Radiotherapy and Immune-Checkpoint Therapy

被引：0
|
作者：
Son, C. [1 ]
Moey, M. [2 ]
Naqash, A. [3 ]
Walker, P. [4 ]
Peach, M. S. [5 ]
Ju, A. W. [5 ]
机构：
[1] East Carolina Univ, Brody Sch Med, Greenville, NC 27858 USA
[2] East Carolina Univ, Dept Cardiovasc Sci, Brody Sch Med, Greenville, NC 27858 USA
[3] East Carolina Univ, Brody Sch Med, Dept Hematol Oncol, Greenville, NC 27858 USA
[4] NCI, Affiliat Div Canc Treatment & Diag, Bethesda, MD 20892 USA
[5] East Carolina Univ, Brody Sch Med, Dept Radiat Oncol, Greenville, NC 27858 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2021年 / 111卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2467
引用
收藏
页码：E235 / E236
页数：2
相关论文
共 50 条
  • [1] Cardiotoxicity in cancer patients treated with immune-checkpoint inhibitors
    Franco, F. F.
    Garitaonaindia, Y.
    Blanco Clemente, M.
    Torrente, M.
    Calvo de Juan, V.
    Collazo Lorduy, A.
    Gutierrez, L.
    Sanchez, J. C.
    del Alba Baamonde, M. A. Gonzalez
    Royuela, A.
    Visedo, G.
    Gonzalez, S. C.
    Martinez Cutillas, M.
    Traseira Puchol, C.
    Aguado, R.
    Mitroi, C. D.
    Provencio, M.
    ANNALS OF ONCOLOGY, 2021, 32 : S1406 - S1406
  • [2] Cardiotoxicity in cancer immune-checkpoint therapy: Mechanisms, clinical evidence, and management strategies
    Sun, Jin-Yu
    Qu, Qiang
    Lou, Yu-Xuan
    Hua, Yang
    Sun, Guo-Zhen
    Sun, Wei
    Kong, Xiang-Qing
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 344 : 170 - 178
  • [3] Cardiotoxicity of Immune Checkpoint Inhibitors in Patients with Lung Cancer
    Chitturi, Kalyan R.
    Araujo-Gutierrez, Raquel
    McLean, Edward T.
    Xu, Jiaqiong
    Bhimaraj, Arvind
    Guha, Ashrith
    Hussain, Imad
    Trachtenberg, Barry H.
    JOURNAL OF CARDIAC FAILURE, 2019, 25 (08) : S50 - S50
  • [4] Incidence of Pneumonitis in Metastatic Lung Cancer Patients Receiving Immune Checkpoint Inhibitors With or Without Thoracic Radiation Therapy
    Hwang, W.
    Niemierko, A.
    Willers, H.
    Gainor, J.
    Keane, F. K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : S150 - S150
  • [5] THE RISK OF DIARRHEA AND COLITIS IN PATIENTS WITH LUNG CANCER UNDERGOING IMMUNE-CHECKPOINT INHIBITOR THERAPY
    Bishay, Kirles
    Tandon, Parul
    Bourassa-Blanchette, Samuel
    Parlow, Simon
    Laurie, Scott
    McCurdy, Jeffrey D.
    GASTROENTEROLOGY, 2018, 154 (06) : S104 - S105
  • [6] Reported Cardiovascular Events in Lung Cancer Patients after Immune-Checkpoint Inhibitor Therapy
    Yeung, S. -C.
    Qdaisat, A.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S78 - S78
  • [7] Role of immune-checkpoint inhibitors in lung cancer
    Jain, Prantesh
    Jain, Chhavi
    Velcheti, Vamsidhar
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2018, 12
  • [8] Clinical Relevance of Targeted Therapy and Immune-Checkpoint Inhibition in Lung Cancer
    Leone, Gian Marco
    Candido, Saverio
    Lavoro, Alessandro
    Vivarelli, Silvia
    Gattuso, Giuseppe
    Calina, Daniela
    Libra, Massimo
    Falzone, Luca
    PHARMACEUTICS, 2023, 15 (04)
  • [9] Cardiotoxicity following thoracic radiotherapy for lung cancer
    Walls, Gerard M.
    Bergom, Carmen
    Mitchell, Joshua D.
    Rentschler, Stacey L.
    Hugo, Geoffrey D.
    Samson, Pamela P.
    Robinson, Clifford G.
    BRITISH JOURNAL OF CANCER, 2025, 132 (04) : 311 - 325
  • [10] A decade of immune-checkpoint inhibitors in cancer therapy
    Caroline Robert
    Nature Communications, 11
12345